Skip to main content

Table 1 Clinical characteristics and the proportion of SEMG+ and SEMG− in subjects

From: Relationship between Semenogelins bound to human sperm and other semen parameters and pregnancy outcomes

Characteristics

Patients (N = 142)

Control (N = 13)

Mean ± SD

Median

Min-max

Mean ± SD

Median

Min-max

Age (years)

36.5 ± 6.6

35.5

21–60

30.1 ± 4.1

29.5

25–36

Vol (mL)

4.25 ± 1.73

3.75

1.2–9.3

N/A

N/A

N/A

Conc (×106/mL)

50.6 ± 58.0

33.9

0.0004–400

76.8 ± 7.3

81.5

45.9–167.8

Mot (%)

27.5 ± 19.9

25.75

0–86.1

63.4 ± 2.1

61.05

50.8–86.6

TSC (×106/mL)

208.7 ± 19.8

143.5

0.003–1475

N/A

N/A

N/A

Viability (%)

55.76 ± 19.3

58.7

1.8–87.6

N/A

N/A

N/A

SEMG+ (%)

71.2 ± 20.2

73.5

12.2–99.2

20.0 ± 11.8

18.6

6.1–53.2

SEMG− (%)

28.8 ± 20.2

26.5

0.8–87.8

80.0 ± 11.8

81.4

46.8–93.9

  1. SEMG+ SEMG-positive spermatozoa, SEMG− SEMG-negative spermatozoa; Patients: male infertile patients; Control: normal healthy male subjects with pregnant wives
  2. Mean values of each parameter for patients and control subjects were compared using Wilcoxon rank sum test, which revealed significant differences concerning all parameters compared
  3. Vol (semen volume)
  4. N/A (not applicable)
  5. Conc (sperm concentration)
  6. Mot (total sperm motility)
  7. TSC (total sperm count)
  8. Viability (sperm viability)
Back to article page

Basic and Clinical Andrology

ISSN: 2051-4190